Last updated:11.10.2020 | 18:18 GMT | the health
White Oak in the USA.
The US Food and Drug Administration (FDA) decided to withdraw the drug “metformin hydrochloride” used in treating diabetes due to its high content of carcinogens.
She said that the company producing this drug (Marksans Pharma Limited), after the tests, “noticed that the content of NDMA in some parts exceeds the acceptable daily intake (ADI) (…) therefore, in terms of Extreme caution … “, I decided to expand the scope of the withdrawal process from the markets that it started last June to include all types and forms of this drug.
The problem with this drug is that it contains a high percentage of the substance known as N-nitrosodimethylamine, which causes cancer, although it is able to lower the level of glucose in the blood of people with type 2 diabetes.
However, the US Food and Drug Administration believes that “it may be dangerous for type 2 diabetes patients to stop taking metformin without first speaking to a health care professional,” according to the American newspaper, “The New York Post.”
These were the details of the news Reasons for withdrawing a popular drug for treating diabetes 2 for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at eg24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.